Assembly Bill A8664

2025-2026 Legislative Session

Relates to the administration of reversible progestin-only contraceptive injections

download bill text pdf

Sponsored By

Current Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

2025-A8664 (ACTIVE) - Details

See Senate Version of this Bill:
S8364
Current Committee:
Assembly Rules
Law Section:
Education Law
Laws Affected:
Amd §§6802 & 6801, Ed L

2025-A8664 (ACTIVE) - Summary

Relates to the administration of reversible progestin-only contraceptive injections; provides that no pharmacist shall administer reversible progestin-only contraceptive injections without receiving training satisfactory to the commissioner of education and the commissioner of health.

2025-A8664 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8664
 
                        2025-2026 Regular Sessions
 
                           I N  A S S E M B L Y
 
                               May 23, 2025
                                ___________
 
 Introduced by M. of A. McDONALD -- read once and referred to the Commit-
   tee on Higher Education
 
 AN  ACT to amend the education law, in relation to the administration of
   reversible progestin-only contraceptive injections
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section  1.  Subdivision  22  of  section 6802 of the education law is
 amended by adding a new paragraph c to read as follows:
   C. THE ADMINISTRATION OF  A  REVERSIBLE  PROGESTIN-ONLY  CONTRACEPTIVE
 INJECTION  APPROVED  BY  THE  U.S.  FOOD  AND  DRUG  ADMINISTRATION,  AS
 PRESCRIBED OR ORDERED BY A LICENSED PRESCRIBER, ACTING WITHIN THE  SCOPE
 OF  THEIR  PRACTICE  IN  THIS  STATE  AND IN ACCORDANCE WITH REGULATIONS
 PROMULGATED BY THE COMMISSIONER, PROVIDED THAT:
   (1) SUCH ADMINISTRATION IS CONDUCTED PURSUANT TO A VALID  PATIENT-SPE-
 CIFIC PRESCRIPTION OR PATIENT-SPECIFIC ORDER.
   (2)  THE  PHARMACIST  SHALL  NOTIFY  THE  LICENSED PRESCRIBER THAT THE
 ADMINISTRATION IS COMPLETE WITHIN FIVE DAYS AND SHALL CONVEY SUCH INFOR-
 MATION TO THE PRESCRIBER BY MAKING AN ENTRY INTO AN INTEROPERABLE  ELEC-
 TRONIC MEDICAL RECORDS SYSTEM, AN ELECTRONIC PRESCRIBING TECHNOLOGY OR A
 PHARMACY RECORD, OR BY USING FACSIMILE, ELECTRONIC TRANSMISSION OR OTHER
 ELECTRONIC MEANS.  IF AN ELECTRONIC MEANS DESCRIBED IN THIS SUBPARAGRAPH
 IS  NOT  AVAILABLE  TO  THE PHARMACIST AT THE TIME OF COMMUNICATION, THE
 PHARMACIST OR PHARMACIST'S DESIGNEE MAY COMMUNICATE THE  INFORMATION  BY
 TELEPHONE.    NOTIFICATION  SHALL ALSO BE REQUIRED IF A PATIENT DOES NOT
 RECEIVE AN ADMINISTRATION OR IF THE PATIENT EXPERIENCES ANY SIDE EFFECTS
 OR ADVERSE REACTIONS TO THE MEDICATIONS. ADMINISTRATION  IN  A  PHARMACY
 SHALL  NOT  COMMENCE  UNTIL  AFTER  THE PATIENT HAS RECEIVED THE INITIAL
 INJECTION AND IS CONSIDERED ELIGIBLE FOR MAINTENANCE  TREATMENT  BY  THE
 LICENSED PRESCRIBER.
   (3)  SUCH  PRESCRIPTION  MAY BE SUBJECT TO REASSESSMENT AT APPROPRIATE
 INTERVALS, AS DETERMINED BY THE LICENSED PRESCRIBER.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD13237-02-5
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.